Carcinosarcomas (malignant mixed Mullerian tumors) of the uterus: Morphology, pathogenetic aspects and prognostic factors;Karzinosarkome (maligne Müller-Mischtumoren) des Uterus: Morphologie, molekulare Pathogenese und morphologische Prognosefaktoren

Pathologe

Volumn 30, Issue 4, 2009, Pages 292-301

  Horn, L C ^a   Dallacker, M ^a   Bilek, K ^b  

^a UNIVERSITY OF LEIPZIG   (Germany)

^b UNIVERSITY HOSPITAL LEIPZIG   (Germany)

Author keywords

Carcinosarcoma; Endometrium; Histology; Malignant mixed Mullerian tumor; Uterus

Indexed keywords

KI 67 ANTIGEN;

ADENOSARCOMA; CANCER STAGING; CANCER SURVIVAL; CARCINOSARCOMA; CLEAR CELL CARCINOMA; CONTROLLED STUDY; DIFFERENTIAL DIAGNOSIS; ENDOMETRIOID CARCINOMA; ENDOMETRIUM CARCINOMA; HUMAN; IMMUNOHISTOCHEMISTRY; LYMPH NODE METASTASIS; MESENCHYMOMA; MICROSCOPY; PROGNOSIS; REVIEW; TUMOR VOLUME; UTERINE CERVIX TUMOR; UTERUS SARCOMA;

CARCINOMA, ENDOMETRIOID; CARCINOSARCOMA; CERVIX UTERI; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; LYMPHATIC METASTASIS; MYOMETRIUM; NEOPLASM STAGING; PROGNOSIS; SURVIVAL RATE; UTERINE CERVICAL NEOPLASMS; UTERINE NEOPLASMS;

EID: 68149171932     PISSN: 01728113     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00292-009-1153-0     Document Type: Review

References (10)

1. Acharya S, Hensley ML, Montag AC, Fleming GF (2005) Rare uterine cancers. Lancet Oncol 6:961-971
2. Amant F, Cadron I, Fuso L et al (2005) Endometrial carcinosarcomas have a different prognosis and pattern of spread compared to high-risk epithelial endometrial cancer. Gynecol Oncol 98(2):274-280
3. Bodner-Adler B, Bodner K, Obermair A et al (2001) Prognostic parameters in carcinosarcomas of the uterus: a clinico-pathologic study. Anticancer Res 21(4B):3069-3074
4. Callister M, Ramondetta LM, Jhingran A et al (2004) Malignant mixed Müllerian tumors of the uterus: analysis of patterns of failure, prognostic factors and treatment outcome, lnt J Radiat Oncol Biol Phys 58(31:786-796
5. McCluggage WG (2002) Malignant biphasic uterine tumours: carcinosarcomas or metaplastic carcinomas? J Clin Pathol 55(5):321-325
6. Nordal RR, Kristensen GB, Stenwig AE et al (1997) An evaluation of prognostic factors in uterine carcinosarcoma. Gynecol Oncol 67(3):316-321
7. Seidman JD, Chauhan S (2003) Evaluation of the relationship between adenosarcoma and carcinosarcoma and a hypothesis of the histogenesis of uterine sarcomas, lnt J Gynecol Pathol 22(1 ):75-82
8. Silverberg SG, Major FJ, Blessing JA et al (1990) Carcinosarcoma (malignant mixed mesodermal tumor) of the uterus. A Gynecologic Oncology Group pathologic study of 203 cases, lnt J Gynecol Pathol 9(1):1-19
9. Vaidya AP, Horowitz NS, Oliva E et al (2006) Uterine malignant mixed mullerian tumors should not be included in studies of endometrial carcinoma. Gynecol Oncol 103(2):684-687
10. Yamada SD, Burger RA, Brewster WR et al (2000) Pathologic variables and adjuvant therapy as predictors of recurrence and survival for patients with surgically evaluated carcinosarcoma of the uterus. Cancer 88(12):2782-2786